https://www.betabionics.com/wp-content/uploads/2023/01/dark-green-beta-bionics-hero.svg
0
0
Karen Hynes
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Karen Hynes2023-01-04 18:45:562023-01-04 20:43:37Beta Bionics Appoints Dr. Steven Russell as Chief Medical Officer in Preparation for the Commercial Launch of the iLet Bionic Pancreas System
https://www.betabionics.com/wp-content/uploads/2022/11/xlargeWebP_adolescent_04_hero_0c39f2af7c.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2022-08-15 04:09:392022-12-22 17:07:12Beta Bionics Appoints Sean Saint as CEO and Board Member
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_senior_05_hero_5dac653c94.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2022-06-09 06:03:312022-12-22 17:11:28The Insulin-Only Bionic Pancreas Pivotal Trial Showed Consistent Mean HbA1c Reductions Across a Variety of Subgroups at ADA’s 82nd Scientific Sessions
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_senior_03_hero_014ebde6fc.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2022-06-01 06:08:332022-12-22 17:10:34Pivotal Trial Results of the iLet® Bionic Pancreas to Be Presented at the ADA’s 82nd Scientific Sessions
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_adolescent_03_hero_e1a7e66a88.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2022-05-10 06:10:272022-12-22 17:09:36Beta Bionics Appoints Gilad Glick to the Board of Directors and Veena Rao, Ph.D. as Chief Commercial Officer
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_family_07_hero_fcb89ddff0.webp
1064
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2022-04-30 06:22:392022-12-22 17:09:15The iLet® Bionic Pancreas Significantly Reduced HbA1c and Improved Time in Range vs Standard of Care for a Diverse Range of People with Type 1 Diabetes
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_about_us_whoweare_3x2_282efac55a.webp
1067
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2022-04-25 06:24:062022-12-22 17:08:40Pivotal Trial Results of the iLet® Bionic Pancreas To Be Presented at ATTD
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_Adolescent_05_hero_028c97d898.webp
581
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2022-03-02 06:24:562022-12-22 17:15:31Beta Bionics Announces Executive Leadership and Board Transitions in Preparation for Commercialization of the iLet® Bionic Pancreas System
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_family_04_hero_2e349eb35c.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2022-02-17 06:25:332022-12-10 04:01:37Beta Bionics Announces Closing of $57 Million Series C Financing
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_adult_01_hero_fab49c21f0.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2021-12-22 06:26:062022-12-10 04:01:37Beta Bionics Announces Data Lock of the Insulin-Only Bionic Pancreas Pivotal Trial and Enrollment into the Screening Protocol of the Bihormonal Bionic Pancreas Pivotal Trial
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_family_01_hero_8fca9d239d.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2021-05-06 06:26:492022-12-10 04:01:37Beta Bionics Announces Appointment of Christy Jones to Board of Directors
https://www.betabionics.com/wp-content/uploads/2022/12/woman-and-children-looking-at-ocean.jpg
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2021-02-09 06:27:362022-12-22 17:16:30Beta Bionics announces the appointment of Martha Goldberg Aronson as Chair of its Board of Directors
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_family_05_hero_76618d7210.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2020-12-30 06:28:102022-12-22 17:16:44Beta Bionics appoints Beth Brooke to its Board as Independent Director
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_family_02_hero_2efa21a516.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2020-02-20 06:28:492022-12-22 17:16:57Beta Bionics appoints Martha Aronson and Sean Carney to its Board as Independent Directors
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_adolescent_01_hero_62f03a579a.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2019-12-10 06:29:202022-12-22 17:17:10Beta Bionics receives FDA breakthrough device designation for the iLet™ Bionic Pancreas System
https://www.betabionics.com/wp-content/uploads/2022/11/xlargeWebP_adolescent_04_hero_0c39f2af7c.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2019-12-03 06:29:512022-12-22 17:18:07Encouraging results of pilot study testing bionic pancreas in cystic fibrosis-related diabetes published in journal of cystic fibrosis
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_senior_04_hero_6e2d9ee7da.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2019-07-17 06:30:292022-12-22 17:18:34Beta Bionics and ConvaTec announce partnership to bring unomedical infusion set portfolio to the iLet™ Bionic Pancreas System
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_family_09_hero_cf30f9d055.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2019-07-01 06:30:592022-12-22 17:18:49Beta Bionics announces closing of a $63 million Series B2 financing, bringing the total Series B and B2 financings to $126 million
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_family_06_hero_742403d9ff.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2019-06-06 06:31:362022-12-22 17:19:06Beta Bionics and Zealand Pharma announce superior glycemic control in phase 2 home-use clinical trial testing the iLet™ Bionic Pancreas using dasiglucagon
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_family_08_hero_7f96dc901f.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2019-05-22 06:32:082022-12-22 17:19:32Beta Bionics and Zealand Pharma initiate home-use trial of the iLet™ bionic pancreas with dasiglucagon for autonomous bihormonal treatment of Type 1 diabetes
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_senior_05_hero_5dac653c94.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2019-01-08 06:32:332022-12-22 17:19:46Beta Bionics Announces Final Closing of Its $63 Million Series B Financing
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_senior_03_hero_014ebde6fc.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2018-10-02 06:33:002022-12-22 17:20:00Beta Bionics awarded up to $2 million NIH small business innovation research (SBIR) grant
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_adolescent_03_hero_e1a7e66a88.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2018-09-17 06:33:282022-12-22 17:20:10Beta Bionics secures an initial $50 million Series B round
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_family_07_hero_fcb89ddff0.webp
1064
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2018-07-12 06:33:542022-12-22 17:20:24Beta Bionics Announces Start of Home-Use Clinical Trials with the iLet™ Bionic Pancreas System and Receives IDE Approval from the FDA to Expand its Clinical Trials to Include the Senseonics Eversense CGM Integrated into the iLet
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_senior_02_hero_fb88c6bf7f.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2018-05-21 06:34:262022-12-22 17:20:38Beta Bionics Receives IDE Approval from the FDA to Begin a Home-Use Clinical Trial Testing the New iLet™ Bionic Pancreas System
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_senior_01_hero_2e17d1718f.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2017-12-21 06:35:102022-12-22 17:20:49Zealand Pharma boosts collaboration with Beta Bionics to advance development of its dasiglucagon in the iLet™
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_Adolescent_05_hero_028c97d898.webp
581
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2017-06-22 06:35:472022-12-10 04:01:38Phase 2a trial results support development of dasiglucagon in the iLet™ pump system for type 1 diabetes
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_adolescent_07_hero_39c584dbbe.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2016-12-13 06:36:232022-12-10 04:01:38Zealand initiates Phase IIa clinical trial with dasiglucagon in a dual-hormone artificial pancreas system from Beta Bionics
https://www.betabionics.com/wp-content/uploads/2022/12/xlargeWebP_family_04_hero_2e349eb35c.webp
580
1600
Chris Howell
https://www.betabionics.com/wp-content/uploads/2022/12/betabionics-logo-black.svg
Chris Howell2016-06-10 06:36:542022-12-10 04:01:38Zealand and Beta Bionics to collaborate on the development of a first-in-class dual-hormonal bionic pancreas system for treatment of people with type 1 diabetesJust email us.
